Clinical Professor, University of British Columbia and gynecologic oncologist/clinician scientist Dr. Carey runs a translational cancer research program studying preclinical drug evaluation and predictive biomarker discovery in rare and aggressive gynecological cancers. Dr. Carey is co-chair of the gynecologic disease site group for the Canadian Cancer Trials Group (CCTG), and a member of the Gynecological Cancer Intergroup, an international clinical trials cooperative. Dr. Carey is a member of the Gynecologic Cancer Steering Committee providing oversight for the review and approval of clinical trials for the National Clinical Trials Network under the auspices of the National Cancer Institute.

Links
ResearchGate

Dr. Lehár advises a portfolio of biotechs, incubators, & venture funds. He is also co-founding stealth startups building expert foundation models for life sciences. Previously, Dr. Lehár led cross-functional teams and drove strategic initiatives or scientific projects for biotech companies (most recently Owkin), Google/Verily, and big pharma (J&J, Merck, Novartis). His first career in astrophysics focused on gravitational lensing at Harvard, Cambridge University, & MIT.

Links
Google Scholar
LinkedIn

A Professor of Computing Science at Simon Fraser University in Burnaby, British Columbia. He received a Diplom (M.Sc.) in Computer Science from University of Dortmund, Germany, in 1984 and a Ph.D. in Computer Science from ETH Zurich, Switzerland, in 1990. Dr. Ester is a co-director of the Databases and Data Mining Laboratory and member of the Omics Data Science Research Cluster. His research interests are in Data Mining and Machine Learning, in particular causal pattern discovery, transfer learning, network analysis, and recommender systems. Much of his research is driven by bio-medical applications such as patient stratification and drug response prediction. His methods are typically based on Probabilistic Graphical Models and Deep Neural Networks.
Dr. Ester is a world leader in Machine Learning and a strong supporter of using Machine Learning in biotechnology.

Links
Google Scholar
Wikipedia

Head of Molecular Pathology & Cell Imaging Core Facility, and a Senior Research Scientist at the Vancouver Prostate Centre and an Associate Professor, Department of Urologic Sciences, University of British Columbia. He is a molecular biologist specialized in cancer tumor-associated stress signaling pathways and tumor targeting systems. Dr. Daugaard is also a decorated entrepreneur founding two highly successful companies as an outcome of his research.

Links
Google Scholar

Dr. Kwon is a Professor and Gynecologic Oncologist at the University of British Columbia, Vancouver General Hospital and BC Cancer in Vancouver.  She completed her fellowship training at the University of Toronto, Masters degree in Public Health at Harvard, and post-doctorate at the M.D. Anderson Cancer Center in Houston.  She is the Chair of the provincial Gynecology Surgical Tumour Group, Research and Outcomes Evaluation Committee (ROEC), and Priorities and Evaluation Committee (PEC) at BC Cancer, and co-chair of the National BRCA+ Collaborative in Canada.  Her academic interests include economic analyses, gynecologic cancer prevention and survivorship strategies, and hereditary cancer syndromes.  

Dr. Zhou the Founder and CEO of Kalino Bio, a Vancouver-based company developing next-generation medicine to address unmet medical needs in companion animal health. Dr. Zhao holds a PhD in Chemistry from the University of British Columbia and brings pharmaceutical development expertise from her tenure at Genentech, where she contributed to biologics characterization and development. Prior to founding Kalino Bio, she served as Regional Director at Mitacs, where she drove significant expansion of research funding across British Columbia and secured a landmark $50M government contract. A recognized leader in Canada's innovation ecosystem, she sits on the board of the Vancouver Entrepreneurs Forum and serves as co-chair of GVBOT's Scale-up Centre for SMEs. She also teaches AI applications for business as part-time faculty at Simon Fraser University. Dr. Zhao holds a BSc from Peking University, a mini-MBA from the Sauder School of Business at UBC, and is a recipient of the UBC Chemistry Young Alumni Award.

Dr. Mannas is a dedicated surgeon-scientist specializing in prostate cancer research, with a focus on the development and application of innovative diagnostic technologies such as Stimulated Raman Histology (SRH) and artificial intelligence (AI). He completed a Master's of Science in Clinical Investigation at NYU Langone Health, where he concentrated on Health Innovation and Technology. Dr. Mannas' research has demonstrated the significant potential of SRH and AI algorithms in improving the precision and accuracy of prostate cancer diagnosis, expediting the diagnostic process, and enhancing molecular profiling of prostate tissue samples. As a member of the Vancouver Prostate Centre (VPC) team, Dr. Mannas has access to state-of-the-art research facilities and a network of distinguished collaborators in translational research, pathology, and imaging. The Department of Urologic Sciences at the University of British Columbia (UBC) supports him with dedicated research time, mentorship, and minimal administrative or teaching responsibilities. Dr. Mannas has received prestigious awards such as the Innovations Pathway Program Award from the British Columbia Ministry of Health, Strategy and Innovation Division, highlighting his outstanding contributions to prostate cancer research.